Evidence map›Paper›PMID 35910943›Full record

ArticleResearch and practice in thrombosis and haemostasis2022

Incident thrombus location and predicting risk of recurrent venous thromboembolism.

Sara C Lidstrom, Kerri L Wiggins, Laura B Harrington, Barbara McKnight, Marc Blondon, Nicholas L Smith

Open access · goldAbstract read
In one paragraph

Article in Research and practice in thrombosis and haemostasis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Incident thrombus location and predicting risk of recurrent venous thromboembolism.Research and practice in thrombosis and haemostasis · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Sara C LidstromDepartment of Epidemiology University of Washington Seattle Washington USA.
Kerri L WigginsDepartment of Medicine University of Washington Seattle Washington USA.
Laura B HarringtonDepartment of Epidemiology University of Washington Seattle Washington USA.
Barbara McKnightDepartment of Biostatistics University of Washington Seattle Washington USA.
Marc BlondonDivision of Angiology and Hemostasis Geneva University Hospitals and Faculty of Medicine Geneva Switzerland.ORCID https://orcid.org/0000-0001-7032-9491
Nicholas L SmithDepartment of Epidemiology University of Washington Seattle Washington USA.ORCID https://orcid.org/0000-0003-3483-353X
University of Washington · USKaiser Permanente · USKaiser Permanente Washington Health Research Institute · US

Funding

Estrogens and pharmacogenetic risks of venous thrombosis in postmenopausal womenR01HL073410 · NHLBI · UNIVERSITY OF WASHINGTON · PI SMITH, NICHOLAS L · 2004 to 2012
$4.8M
Pharmacologic and pharmacogenetic associations with recurrent venous thrombosisR01HL095080 · NHLBI · UNIVERSITY OF WASHINGTON · PI SMITH, NICHOLAS L · 2008 to 2012
$2.9M
Population genomic variation, functional biology, and the risk of venous thrombosisR01HL134894 · NHLBI · UNIVERSITY OF WASHINGTON · PI LOWENSTEIN, CHARLES J, SMITH, NICHOLAS L · 2017 to 2020
$2.9M
Physical Activity, Sedentary Behavior, and Venous Thromboembolism RiskK01HL139997 · NHLBI · KAISER FOUNDATION RESEARCH INSTITUTE · PI HARRINGTON, LAURA BRIENNE · 2018 to 2022
$942k
NHLBI NIH HHS K01 HL139997NHLBI NIH HHS R01 HL073410NHLBI NIH HHS R01 HL095080NHLBI NIH HHS R01 HL134894
6 · The paper itself

Abstract

Background: Understanding venous thromboembolism (VTE) recurrence risk is central to determining the appropriate treatment course. Whether this risk varies after discontinuing anticoagulation or overall by type of incident event (pulmonary embolism [PE] vs deep vein thrombosis [DVT]) and by the detailed location of the DVT needs further clarification. Methods: In this population-based inception cohort of incident VTE cases with follow-up by electronic health record review, incident DVT was categorized as distal, popliteal, or iliofemoral. We used the Fine-Gray regression model to describe the predictive association of the thrombus location with the risk of recurrence before death. Results: Among 2766 participants with an incident event from 2002 to 2010, 1713 (62%) ceased anticoagulation and were followed for recurrent events; 301 events were observed during the 4.5 years of follow-up. Relative to participants with an incident thrombus in an iliofemoral location and no PE, those with a thrombus in a popliteal location and no PE had a similar risk of recurrence (adjusted subdistribution hazard ratio [aSHR], 0.82 [95% confidence interval (CI), 0.57-1.19]), while those with a thrombus in a distal location and no PE and those with a thrombus that included a PE had lower risk of recurrence: aSHR, 0.34 (95% CI, 0.20-0.57); and aSHR, 0.58 (95% CI 0.45-0.76), respectively. Conclusions: The findings of this population-based inception cohort confirm that the risk of recurrent VTE after discontinuing anticoagulants is similar after iliofemoral and popliteal DVT but is lower after distal DVT. Recurrence may be lower after PE than proximal DVT.

Indexed as

deep vein thrombosisfollow‐up studieshumanspulmonary embolismrecurrencevenous thromboembolism

Identifiers

PMID35910943
PMCPMC9326286
OpenAlexW4288069999

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.